Five Biotechnologies That Will Fade Away This Decade
Summary
Within biotechnology’s short history, we have already seen approaches from the ’90s such as Southern blots that look at sizes and amounts of DNA, and antisense therapies, are being replaced.This is the approach that does high-speed scanning for markers across the complete sets of DNA, or genomes, among many individuals to spot small variations that might be associated with a particular disease.Biomarker signatures as commercially viable robust markers akin to cholesterol or estrogen receptor positivity for breast cancer.VCs would be smart to invest in platforms and those who can offer up access to the evolving models of disease from which will spring the dynamic biomarkers.This means biologists will need to start pooling their knowledge through social networking channels, not unlike how computer scientists have long done for open source software development.
Classifications
AskAI Classifications
LabelsLinked Companies
